Thoratec Corporation (Thoratec) is a manufacturer of circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets products that are used by physicians and hospitals for cardiac assist, vascular and diagnostic applications. Thoratec operates in two business segments: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. Cardiac assist and vascular graft products represented 61% of Thoratec's product sales during the fiscal year ended December 29, 2007, (fiscal 2007). Point-of-care blood diagnostics test systems and services and incision products amounted to 39% of the Company's total product sales in 2007.
Thoratec Corporation
NASDAQ:THOR ISIN:US8851753074
News
Last Friday Australian shares ended higher, capping a winning week after reports that the US government was working on a program to help troubled US home owners. The benchmark S&P/ASX200 rose 44.8 points, or 1.27 per cent, at 3,559.1, while the broader All Ordinaries gained 38.2 points, or 1.1 per cent to 3,496.7. The Obama administration's seeking to lower expectations of a quick fix to the financial crisis and the coming earnings reports may send the market to a negative territory.
###
55,065 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 11) (Last 30 Days: 36) (Since Published: 7331)